肠道连接:探索在淋巴瘤治疗中实施肠道微生物代谢物的可能性
Ahmad K Al-Khazaleh1, Dennis Chang1, Gerald W Münch2
1NICM Health Research Institute, Western Sydney University, Penrith, NSW 2751, Australia.
Cancers
|April 27, 2024
概括
肠道微生物群通过其代谢产物影响淋巴瘤的发展. 有益的代谢物可能会预防淋巴瘤,而有害的代谢物,如脂多糖类会促进炎症和癌症风险.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物群失调与淋巴瘤的发展有关.
- 微生物代谢物对宿主生理学和疾病风险产生影响.
- 由于脂多糖类等代谢物的慢性炎症可能会增加淋巴瘤的风险.
研究的目的:
- 审查肠道微生物代谢物在淋巴瘤中的作用.
- 探索这些代谢物的潜在治疗应用.
- 突出这一领域的未来研究方向.
主要方法:
- 对肠道微生物群,代谢物和淋巴瘤研究的文献综述.
- 对代谢物功能的临床前数据的分析 (例如,SCFA,urolithin A).
- 讨论分子机制和与化疗的相互作用.
主要成果:
- 肠道微生物代谢物在淋巴瘤中具有双重作用.
- 短链脂肪酸显示出抗炎和潜在的预防作用.
- 乌罗立A在体外表现出免疫调节和抗增殖特性.
结论:
- 肠道微生物代谢物对淋巴瘤的发病和进展具有重要意义.
- 需要进一步的研究来了解它们的治疗潜力和机制.
- 准肠道微生物组为淋巴瘤治疗提供了新的策略.
相关概念视频
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


